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Abstract
Foot-and-mouth disease Virus (FMDV) is an economically important, highly contagious picornavirus that affects both wild
and domesticated cloven hooved animals. In developing countries, the effective laboratory diagnosis of foot-and-mouth
disease (FMD) is often hindered by inadequate sample preservation due to difficulties in the transportation and storage of
clinical material. These factors can compromise the ability to detect and characterise FMD virus in countries where the
disease is endemic. Furthermore, the high cost of sending infectious virus material and the biosecurity risk it presents
emphasises the need for a thermo-stable, non-infectious mode of transporting diagnostic samples. This paper investigates
the potential of using FMDV lateral-flow devices (LFDs) for dry transportation of clinical samples for subsequent nucleic acid
amplification, sequencing and recovery of infectious virus by electroporation. FMDV positive samples (epithelial suspensions
and cell culture isolates) representing four FMDV serotypes were applied to antigen LFDs: after which it was possible to
recover viral RNA that could be detected using real-time RT-PCR. Using this nucleic acid, it was also possible to recover VP1
sequences and also successfully utilise protocols for amplification of complete FMD virus genomes. It was not possible to
recover infectious FMDV directly from the LFDs, however following electroporation into BHK-21 cells and subsequent cell
passage, infectious virus could be recovered. Therefore, these results support the use of the antigen LFD for the dry, non-
hazardous transportation of samples from FMD endemic countries to international reference laboratories.
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Introduction
Foot-and-mouth disease (FMD) virus (FMDV) (family Picorna-
viridae, genus Aphthovirus) [1] causes a highly infectious and
contagious disease of wild and domesticated cloven-hoofed
animals, with huge potential for rapid spread within susceptible
animal populations. There are seven immunologically distinct
serotypes with more than sixty antigenic variants of the virus.
FMD is endemic in large parts of Asia, Africa and some parts of
South America [2–3]. Based on samples received to the Office
International des Epizooties (OIE)/Food and Agriculture Orga-
nisation of the United Nations (FAO) FMD laboratory Network,
FMD viruses of type O are the most frequently detected serotype,
followed by serotype A. Serotype C has not been isolated from
field cases since 2004, while the southern African serotypes (SAT)
1 to 3 are usually, but not exclusively, found in sub-Saharan Africa
[4].
In developing countries, accurate and timely diagnosis and
reporting of FMD outbreaks is often hindered by low levels local of
infrastructure, such as lack of reliable power supply, inadequate
numbers of suitably trained personnel as well as lack of resources
within national and regional reference laboratories. Therefore
many countries rely on the services of international laboratories
such as those within the OIE/FAO FMD Laboratory Network to
confirm and characterise the strain of virus collected in clinical
material from suspected outbreaks. However, transportation of
potentially infectious samples from the field to these international
centres, poses significant costs and logistical challenges. In
particular, maintenance of the cold chain is important since
inadequately preserved samples are often degraded which
generates difficulties for the reporting laboratory to fully
characterise the field isolate, resulting in a loss of vital information
required for control measures to be implemented. In addition,
sending live infectious FMDV represents a major biosecurity risk,
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in that it could cause further outbreaks in the country of origin, or
result in a major disease incursion elsewhere, including a disease
free country, should the sample fail to be handled correctly during
transport. As a result, there is interest in developing and evaluating
methods that can be used to preserve clinical samples at source in
a form that is non-infectious and less subject to degradation during
transit, but which can be fully recovered upon arrival at the
reference laboratory.
There is a growing body of evidence demonstrating that
preservation of clinical samples at source and full recovery within a
laboratory is indeed possible. Hofmann et al, [5] reported that
FMDV and Classical Swine Fever Virus (CSFV) could be
recovered via electroporation from samples stored in Trizol,
whilst more recently Belsham et al, [6] and Bisht et al, [7]
demonstrated that live FMDV can also be recovered from
commercially available RNA storage buffers via electroporation
[6] and transfection [7]. Both methods, however, still require the
transport of liquids which is not ideal due to the need for
appropriate high bio-secure packaging, maintenance of the cold
chain and also the potential risk of leakage and thus loss of sample
material. In this study we investigated whether a FMDV antigen
lateral flow device (LFDs) (SVANODIP FMDV-Ag) could be used
for dry transportation of FMDV for later nucleic acid amplifica-
tion, sequencing and recovery of live virus.
Materials and Methods
Viruses
Representative archival material from the FAO World Refer-
ence Laboratory for FMD (WRLFMD), Pirbright, UK was used in
this study. These were isolates from cell culture (CC) and epithelial
suspensions (ES) of clinical samples from four FMDV serotypes A,
O, Asia 1 and SAT 1 (Table 1).
Synthetic FMDV RNA
Synthetic viral RNA was generated from a plasmid pT73S
containing full-length genomic sequences of FMDV serotype O
[8] by in vitro transcription using a commercially available T7
RNA polymerase kit (MEGAscript T7 Transcription Kit, Life
technologies, UK) following manufacturer’s guidelines. This RNA
was then purified using a MEGAclear kit following manufacturer’s
guidelines (Life technologies, UK) prior to being used as a positive
FMDV RNA control within the electroporation studies.
Epithelial suspension preparation and testing on Lateral
Flow Devices (LFDs)
ES were prepared using the SVANODIP FMDV-Ag Extraction
kit (Svanova, Uppsala, Sweden) following manufacturer’s guide-
lines. ES were added to FMDV antigen LFDs (SVANODIP
FMDV-Ag LFD, Svanova Biotech AB) as previously published [9]
and following manufacturer’s guidelines. Where CC derived
viruses were used, 6 drops of the cell culture supernatant were
added to each LFD. All LFDs were incubated for 10 minutes at
room temperature (RT) to allow a positive result to develop at the
test-line. For time course evaluation studies, LFDs were sealed in
50 ml falcon tubes or petri dishes with a desiccant and stored at
RT or 37uC.
Elution of nucleic acid from LFDs
Nucleic acid was eluted from five individual sections (1–5;
loading pad (LP): wicking strip (WS): nitrocellulose below antibody
band (NB): nitrocellulose antibody band (AbB): nitrocellulose
above antibody band (NA) or two combined sections (6–7; LP+
WS; NC) of the FMDV positive LFDs (Figure 1). These sections
were excised from each LFD using clean, sterile forceps and
scalpel blade for each device and individually mixed with 100 ml of
elution buffer consisting of RNase inhibitor (20 mM HEPES-
Table 1. Foot-and-mouth disease virus samples used in the study.
Virus Sample type Serotype
TUR 8/1969 ES FMDV O
HKN 10/2005 CC FMDV O
IRN 53/2006 CC FMDV O
UKG 7B/2007 ES FMDV O
BAR 2/2008 CC FMDV O
KUW 2/2008 CC FMDV O
SAU 3/2008 CC FMDV O
O1BFS Field strain CC FMDV O
O1BFS Cell culture adapted virus CC FMDV O
TUR 20/2006 CC FMDV A
IRN 36/2007 CC FMDV A
IRN 1/2008 CC FMDV A
KEN 8/2008 CC FMDV A
BAR 4/2009 CC FMDV A
TUR 4/2013 ES FMDV A
ZAM 5/2008 CC FMDV SAT 1
IRN 15/2001 CC FMDV Asia 1
PAK 9/2013 ES FMDV Asia 1
TUR 2/2014 ES FMDV Asia 1
ES: Tongue epithelial suspension. CC: Cell culture supernatant.
doi:10.1371/journal.pone.0109322.t001
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KOH, pH 7.6; 50 mM KCl; 8 mM DTT; and 50% (v/v) glycerol
- 20 Units/mL, Applied Biosystems, UK) and sterile nuclease-free
water (Ambion, UK) at 1:50 dilution. Where sections were
combined (6–7; LP+WS; NC) these were also added to a total of
100 ml of elution buffer. These sections were removed from the
LFD and added directly to the elution buffer and incubated at RT
for 5 minutes. These tubes were then centrifuged at 3489xg
(Hettich Rotanta 460R) for two minutes to obtain the eluted
nucleic acid. In the case of nitrocellulose (NC) sections, the LFD
was scraped from its plastic backing using a scalpel blade with the
scrapings added directly into 100 ml of elution buffer. Eluted
nucleic acid preparations were stored at 280uC until use.
Real-time rRT-PCR on FMDV RNA eluted from the LFDs
To assess the quality of nucleic acid that was recovered from the
LFDs, reverse transcription real-time PCR (rRT-PCR), utilising
primers and TaqMan probes targeting the 3D region (RNA
polymerase) of the FMDV genome [10], was performed according
to the protocol as previously described [11]. To determine the
limit of detection of the elution process, parallel decimal dilution
series (1:10, 1:100, 1:1K, 1: 10K, 1:100K) of ES from virus isolate
BAR 2/2008 was prepared and applied to LFDs. Eluted nucleic
acid from LP, WS and AbB was subsequently tested by the 3D
rRT-PCR as described above.
Real-time rRT-PCR on FMDV RNA extracted directly from
ES
The ability to detect FMDV-specific RNA by 3D rRT-PCR in
the elution wash from the positive LFDs was directly compared to
RNA extracted from the original sample that had been added to
the LFD. In these experiments, RNA was prepared with an
automated programme (MagNa Pure LC Robot, Roche, UK)
routinely used for extraction of FMDV RNA from clinical samples
[12].
Amplification and sequencing of VP1 from FMDV eluted
from the LFD
To determine whether VP1 sequences could be generated using
RNAs recovered from the LFD, a one-step RT-PCR was
performed [13] utilising forward primers O-1C244F (5’-GCAG-
CAAAACACATGTCAAACACCTT-3’) or O-1C272F (5’-
TBGCRGGNCTYGCCCAGTACTAC-3’) and reverse primer
EUR 2B-52R (5’-GACATGTCCTCCTGCATCTGGTTGAT-
3’) on elution wash collected from LFDs which had been stored at
RT for one month. After PCR, amplification products were
analysed by electrophoresis on a 1.5% agarose gel. Fragments of
appropriate size (O-1244F/EUR2B-52R – 1162-1165 and O-
1272F/EUR2B-52R – 1132-1135 nt) recovered from the gel were
purified (Illustra GFX PCR DNA and Gel Band Purification Kit,
GE Healthcare Life Sciences, UK) as per the manufacturer’s
instructions prior to sequencing as previously described [13]. The
raw data were assembled using the Lasergene 11 suite (DNAS-
TAR, Madison, WI) and further sequence analysis performed
using BioEdit (version 7.0.1) [14].
Amplification of the complete FMD viral genome from
RNA eluted from the LFD
To determine whether sequences comprising the complete
FMD viral genome were recoverable from LFDs, overlapping
fragments were amplified from cDNA. This cDNA was prepared
from eluted nucleic acid from the LP of a LFD containing a
clinical epithelial sample from the 2007 FMD outbreak in the
United Kingdom (UKG 7B/2007) after one month’s storage at
37uC. The method used was as previously described by Cottam et
al, [15], with the exception that the backwards primer used for
reverse transcription was UKFMD Rev (59-GGCGGCC-
GCTTTTTTTTTTTTTTT-39), which targets the poly(A) frag-
ment of the virus genome. A 24th reaction using the last forward
primer and the reverse primer RACE-T21G (59-CAGGAAA-
CAGCTATGACTTTTTTTTTTTTTTTTTTTTTG-39) was
Figure 1. Illustration of a representative FMDV positive LFD and lateral view sketch of internal sections that were used to evaluate
the recovery of RNA; LP: Loading Pad; WS: Wicking strip; NB: Nitrocellulose below Ab Band (NB); Nitrocellulose Ab Band (AbB);
Nitrocellulose above Ab band (NA).
doi:10.1371/journal.pone.0109322.g001
Recovery of Foot-and-Mouth Disease Virus from Lateral-Flow Devices
PLOS ONE | www.plosone.org 3 October 2014 | Volume 9 | Issue 10 | e109322
performed to fully obtain the poly A tract. For each PCR reaction,
negative controls were performed in parallel to detect potential
cross-contamination. PCR amplification products were then
analysed by electrophoresis on a 1.8% agarose gel.
Recovery of infectious FMDV from the LFDs
In vitro electroporation of BHK-21 (Baby Hamster Kidney)
cells was used to determine whether infectious FMDV could be
directly recovered from the LFDs. This involved electroporating
elution wash recovered from six individual LFD sections (Figure 1)
loaded with either 200 ml of O1 BFS Field strain or 200 ml O1 BFS
cell culture adapted virus and an LFD to which synthetic FMDV
RNA had been added were placed in 100 ml elution buffer,
incubated at RT for 10 minutes prior to overlaying directly onto
bovine thyroid primary cell cultures (BTY) grown in tubes. Post
electroporation, two passages, each of two days duration, at 37uC
on BTY cells were undertaken to observe development of
cytopathic effect (CPE).
In subsequent experiments, LFDs loaded with original epithe-
lium suspensions prepared from TUR 4/2013, TUR 2/2014 and
PAK 9/2013 isolates, duplicate LFDs were prepared. One LFD
from each duplicate was processed as describe above with the
exception that the LP and WS were combined as one sample (LP+
WS) as was the NB, NaB and NA (referred to as NC) and the
elution buffer collected was frozen at 280uC for one week prior to
electroporation. The second LFD from each virus was left at RT
for one week prior to elution as described above before being
frozen at 280uC and then electroporated.
BHK-21 cells (800 ml of 26106 cells/ml) were suspended in
electroporation buffer (21 M HEPES pH 7.0, 137 mM NaCl,
5 mM KCl, 0.7 mM Na2HPO4, 6 mM glucose, made up with
RNAse free water and filter sterilised) and mixed with approxi-
mately 50 ml of eluted RNA in a cuvette (0.4 cm, Bio-Rad) and
subjected to a double, square wave, electrical pulse (0.5 ms) of
0.75 kV using a BioRad Gene Pulser X cell electroporation
system. The electroporated cells were subsequently transferred
into a 25 cm2 culture flask with addition of 4 mls of maintenance
media (5% adult bovine serum in Glasgow eagles) and incubated
at 37uC in a CO2 incubator for 24 hours. After freeze/thawing,
supernatant was clarified via centrifugation at 13000xg (Hettich
Rotanta 460R) and 1 ml was transferred onto a monolayer of
primary BTY cells maintained in 2% adult bovine serum in
Glasgow Eagles within tubes (5.5 cm2 Nunclone Delta tubes flat
bottom) and incubated at 37uC in a CO2 incubator for two days
prior to harvesting the clarified supernatant. Two passages, each of
two days duration, at 37uC on BTY cells were undertaken to
observe development of CPE. Specificity of CPE was confirmed by
testing the cell culture supernatant using an antigen capture
ELISA [16–18]. In the case of LFDs loaded with TUR 4/2013,
TUR 2/2014 and PAK 9/2013 a 3D rRT-PCR was performed
on the eluted FMDV as described above.
Statistical Analysis
Differences in cycle threshold (Ct) values between LFD sections
and effect of storage conditions were tested using a one-way
analysis of variance (ANOVA), and where post-hoc testing was
computed using the Tukey’s HSD test variables associated were
tested using the Analysis of Variance (ANOVA). Statistical
analyses were performed and linear regression methods in R
3.1.0 [19].
Results
Detection of FMDV genome from RNA recovered from
LFDs compared to robotically extracted RNA
It was possible to detect FMDV nucleic acid from all sections of
FMDV positive LFDs with Ct values that were similar across the
different sampled sections of the LFD (F4,90 = 0.96, p= 0.434)
(Figure 2). When compared to MagNA pure extracted RNA, the
Ct values derived from eluted RNA were significantly higher
(F5,108 = 6.47, p = 0.000) with an average increase in the Ct values
generated of 4.6460.64 (p= 0.000). In addition, MagNA Pure
extracted RNA had greater dynamic range in the Ct values than
RNA eluted from the LFDs (95PI 16.0760.56 to 25.2761.01)
(Figure 2).
Effect of storage conditions upon the recovery of FMDV-
specific RNA from LFDs
FMD viral genome was detected by 3D rRT-PCR on all
sections of the LFD washed with elution buffer one week and one
month after visual development (Figure 3). However, the length of
time that the LFD had been previous stored was not statistically
associated with variation in Ct values obtained from each of the
LFD section (F2,72 = 1.19, p = 0.311). Statistically different Ct
responses were recorded for each of the LFD section (F4,70 = 4.16,
p = 0.004) with Ct values obtained from the LP being the lowest
(i.e. strongest signal), reporting an average increase of 2.7561.09
in the Ct values produced by the other section of the LFD
(p= 0.627, 0.002, 0.057, 0.236 for WS, NB, AbB and NA,
respectively).
It was also possible to detect FMD viral genome by 3D rRT-
PCR on all sections of the LFD (LFD loaded with ZAM 5/2008;
one LFD used for baseline; triplicate LFDs used either at RT or
37uC) washed with elution buffer after one month from sample
application when stored at both RT (RT, ,25uC) and 37uC
(Figure 4). Ct values derived from FMDV eluted 60 minutes post
development were not statistically different to those obtained (in
triplicate) from LFDs stored at RT and 37uC after one month
(F1,28 = 0.90, p = 0.352) (95PI 17.4760.68 to 19.5860.93 and
17.8160.28 to 20.4861.30 for RT and 37uC, respectively).
Effect of dilution on detection of FMDV genome from
RNA recovered from LFDs
The dilution to which viral RNA could be detected was
dependent upon the section of LFDs from which the RNA was
eluted (Figure 5). For example it was only possible to detect viral
RNA on the WS when the virus was added neat to the LFD,
whereas it was possible to detect viral RNA at dilutions of 1:1000
in elution wash derived from the AbB. The ability to detect viral
genome also correlated with the ability to see the positive band on
the LFD and RNA could not be detected when the antigen test-
line was not present on the LFD.
RT-PCR amplification and sequencing of VP1 from LFDs
Using a one-step RT-PCR it was possible to recover VP1 from
all five sections of the LFD from serotype O isolate BAR 2/2008
(data not shown). Following gel extraction it was also possible to
amplify a 1165 bp (0-1244F/EUR2B-52R) or 1135 bp (0-1272/
EUR2B-52R) product containing the sequence of VP1 which
matched sequence data generated from the same virus passaged
once on BTY (data not shown).
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Use of RT-PCR to amplify fragments comprising the
complete FMDV genome
Using the method described by Cottam et al [15], it was possible
to amplify the complete genome from RNA eluted from the LP of
LFD loaded with a clinical epithelial sample (UKG 7B/2007) and
which had been stored at 37uC for one month, including the S-
fragment of the 59UTR fragment of the virus (Figure 6). Since the
primer used for reverse transcription targeted the poly(A)- tail at
the 39end of the FMDV genome these results provided evidence
that full length FMD viral genomic RNA was present in the LFD
device as a single molecule and thus electroporation to recover the
virus might be achievable.
Recovery of FMDV virus from LFDs
Attempts to recover infectious FMDV from the LP, WS and NC
from LFDs loaded with O1 BFS field strain and O1 BFS cell
culture adapted virus was unsuccessful when the elution wash was
overlaid directly onto a monolayer of BTY cells and passaged
twice on BTY cells. However when the elution wash was
electroporated into BHK-21 cells and subsequently passaged onto
BTY cells, infectious virus was successfully recovered correctly
typed by subsequent antigen ELISA (Table 2). Similar results (with
the exception of the WS from which live virus was not recovered)
were obtained for the LFD containing the positive control
synthetic RNA (pT7S3).
When we extended the investigation to an additional two
serotypes (A and Asia 1) it was possible to recover infectious
FMDV from both the LP/WS and NC when the elution wash was
electroporated into BHK-21 cells the same day and subsequently
passaged onto BTY cells from LFDs loaded with TUR 4/2013
and PAK 9/2013 (Table 2). However, following storage at RT for
one week, infectious virus was only recovered from the LP (LFD
loaded with PAK 9/2013), and NC (LFD loaded with TUR 4/
2013). Where CPE was visible, the supernatants were positively
typed by antigen ELISA to the correct serotype (Table 2). In the
case of the LFD loaded with TUR 2/2014, no infectious virus was
recovered; either the same day, or after one week’s storage at RT.
rRT-PCR was able to detect FMDV genome on all sections of the
LFDs immediately following elution and also following one week’s
storage at RT, even in the case of LFD loaded with TUR 2/2014
which was negative for recovery of infectious FMDV.
Discussion
This study, demonstrates for the first time, that it is possible to
recover full length FMDV RNA from positive LFDs which can be
successfully used as a template for diagnostic rRT-PCR, full
genome amplification, sequencing and recovery of infectious virus
upon electroporation. Thus this paper describes a novel method-
ology which could be applied for the dry, non-hazardous
transportation of samples from FMD endemic countries to
international reference laboratories for viral characterisation
without the worry of degradation of sample. However, the
analytical sensitivity of the FMDV LFD is reported to be
equivalent to the antigen-detection ELISA [20] which is lower
than sensitive molecular detection methods that are widely used
for routine diagnostics. Therefore, this transport method is not
intended to replace routine diagnostic submission for outbreak
Figure 2. Ct values generated from FMDV 3D rRT-PCR performed on sections of 14 separate LFDs and corresponding values
generated for MagNA pure extracted RNA from the equivalent original epithelial suspensions in parallel. LP: Loading Pad; WS: Wicking
strip; NB: Nitrocellulose below Ab Band (NB); Nitrocellulose Ab Band (AbB); Nitrocellulose above Ab band (NA). LFDs spanned four serotypes O (red
dots) (LFDs TUR 8/1969, BAR 2/2008, KUW 2/2008, SAU 3/2008, ZAM 5/2008, HKN 10/2005, IRN 53/2006, UKG 7B/2007, A (blue dots) (LFDs BAR 4/
2009, IRN 1/2008, KEN 8/2008, TUR 20/2006, IRN 36/2007), Asia 1 (grey dots) (IRN 15/2001) and SAT 1 (yellow dots) (ZAM 5/2008).
doi:10.1371/journal.pone.0109322.g002
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Figure 3. Ct values generated from FMDV 3D rRT-PCR performed on sections of 5 separate LFDs and MagNA pure extracted RNA
from the original epithelial suspensions and recorded by time of LFD testing. LP: Loading Pad; WS: Wicking strip; NB: Nitrocellulose below
Ab Band (NB); Nitrocellulose Ab Band (AbB); Nitrocellulose above Ab band (NA). LFDs spanned two serotypes O (red dots) (LFDs HKN 10/2005, UKG
7B/2007) and A (blue dots) (LFDs TUR 20/2006, IRN53/2006, IRN 36/2007).
doi:10.1371/journal.pone.0109322.g003
Figure 4. Box plot of Ct values generated from FMDV 3D rRT-PCR performed on sections of LFDs from serotype SAT 1 isolate (ZAM
5/2008) eluted at one month after LFD testing. LFDs had either been stored at room temperature (RoomT) (green bar) or 37uC (red bar). LP:
Loading Pad; WS: Wicking strip; Nitrocellulose Ab Band (AbB). Dotted blue line represents baseline data (Ct values from LFDs washed on day one).
doi:10.1371/journal.pone.0109322.g004
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surveillance, since a negative LFD does not necessarily define a
negative sample.
Regardless of the storage time or temperature, it was possible to
detect FMDV genome using rRT-PCR from all sections of the
LFDs for all isolates examined. These results are consistent with
findings from Bisht et al, [7] and Hofmann et al, [5] who were also
able to detect FMDV genome from clinical samples which had
been stored for one month at elevated temperatures. However, for
temperature and time of storage, the LP had significantly lower
rRT-PCR Ct values and thus may be more favourable sections to
use for laboratory analysis. This observation is supported by
testing serial dilutions of virus applied to the LP, WS and AbB,
whereby FMDV genome was still detectable at a higher dilutions
for the LP and WS than other sections of the LFD.
It was also possible to amplify and sequence VP1 from all
sections of the LFDs after one month of storage at RT, and
amplify the complete genome from the LP after one month of
storage at 37uC. In fact there was no significant difference between
Ct values derived from LFD membranes stored at RT when
compared to those stored at 37uC. This indicates that the LFD
membranes are suitable surfaces to preserve full length RNA for
extended periods of time regardless of storage temperatures. It
would be of interest to determine whether these observations can
be replicated for samples processed and shipped from the field and
include a range of different serotypes.
A particular focus of this study was to examine whether full
length FMDV RNA could be recovered from the lateral flow
membranes. Following electroporation, it was possible to recover
infectious FMDV that was correctly typed by antigen ELISA.
Although LFDs have not been previously tested, these findings are
consistent with published work [6] that describes recovery of
infectious FMDV from clinical samples preserved in RNA storage
buffers. Electroporation of elution wash one week following
development on the device was less successful for the recovery of
infectious virus. This observation is consistent with data reported
by Hofmann et al, [5], whereby the ability to recover infectious
virus following electroporation of RNA stored in Trizol declined
over time. The success of recovering virus was not related to the
section used on the lateral flow device and suggests that should this
method be adopted for recovery of virus it would be important to
electroporate elution washes from multiple LFD sections to
optimise recovery of infectious full length RNA. Future studies
should extend the storage time and include elevated temperatures
Figure 5. Ct values generated from FMDV 3D rRT-PCR performed on sections of LFDs in dilution series from serotype O isolate (BAR
2/2008) compared against the visual detection on the Ag LFD. LP: Loading Pad; WS: Wicking strip; Nitrocellulose Ab Band (AbB)(+) =
genome detected; (-) = No Ct.
doi:10.1371/journal.pone.0109322.g005
Figure 6. Visualization of the 24 overlapping PCR products
representing the complete FMDV genome generated from the
loading pad (LP) from LFD loaded with UKG 7B/2007. 1.8%
agarose gel stained with ethidium bromide (0.2 mg per ml). Lane 1, S-
fragment of the 59UTR, Lanes 2–22 L fragment, Lanes 23 and 24, poly A
fragment.
doi:10.1371/journal.pone.0109322.g006
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to determine the point at which infectious virus can no longer be
recovered.
Contrary to the findings by Belsham et al, [6] the rRT-PCR Ct
values in this study did not appear to correlate with the ability to
recover infectious virus. For example we were able to recover
infectious virus from TUR 4/2013 (serotype A) and PAK 9/2013
(serotype Asia 1) which had average Ct values of 3062 and 2564
respectively, yet we were unable to recover infectious virus from
TUR 2/2014 (serotype Asia 1) despite average Ct values of 2361.
The findings of this study are therefore more consistent with those
published by Bisht et al, [7] who also reported varied success in
recovery of infectious virus from RNA extracted from clinical
samples despite strong multiplex PCR results [7]. Further
evaluation is required on a greater number of isolates to determine
the optimum method/section of LFD to use for recovery of
infectious FMDV RNA.
Infectious virus was not recovered (absence of CPE) following
direct passage of the elution wash onto BTY cells. It is already
known that purified RNA (non-encapsulated) is not infectious
when inoculated onto susceptible cells for CSFV [21] and
therefore our results suggest that when FMDV is applied to the
lateral flow device, the viral capsid does not remain intact
but disassociates releasing the RNA for preservation on the
membrane. This is a significant finding as it suggests that positive
lateral flow devices may pose little to zero-biorisk should they be
used for transportation of samples between the field and reference
laboratories. In view these data, further work to consider and
agree biosecurity guidelines is required so that these new methods
can be transitioned into the field for the safe preservation and
recovery of FMDV. Furthermore, we aim to continue this work
using additional clinical samples added to the LFD in the field
which have been shipped back to the WRLFMD and to compare
directly to routine virus isolation methods in order to determine
whether there is a difference in the efficiency of infectious virus
recovery.
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Table 2. Antigen (Ag) ELISA results from electroporated BHK cells passed once and twice on BTY cells.
1st BTY Passage 2nd BTY passage Ct values
Sample LFD section CPE Ag ELISA CPE Ag ELISA
O1BFS field strain LP + O + O Not done
NC +/- - + O
WS +/- - + O
O1BFS cell culture LP + O + O
NC +/- - + O
WS + O + O
Positive control (pT7S3) LP +/- - + O
NC +/- - + O
WS - - +/- -
TUR 4/2013 NC (1) + Not done + A 29.85
LP/WS (1) + + A 30.13
NC (2) + + A 33.33
LP/WS (2) - - - 28.08
TUR 2/2014 NC (1) - - - 22.84
LP/WS (1) - - - 22.25
NC (2) - - - 23.75
LP/WS (2) - - - 25.11
PAK 9/2013 NC (1) + + Asia 1 22.12
LP/WS (1) + + Asia 1 30.28
NC (2) - - Asia 1 22.56
LP/WS (2) + + Asia 1 23.92
LP: Loading Pad; WS: Wicking strip; NC: Nitrocellulose. +: Obvious CPE; +/-: Suspected CPE: -: No CPE. O = O serotype detected, A = A serotype detected, Asia 1 = Asia 1
serotype detected. LP/WS: Loading Pad combined with Wicking Strip; NC: Nitrocellulose. (1) = LFDs washed the same day. (2) = LFDs washed one week later.
doi:10.1371/journal.pone.0109322.t002
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